RELXRELX PLC demonstrates strong financial health and consistent performance, with positive thematic alignment. While current technical indicators show mixed signals, the overall outlook is positive for long-term investors seeking stability and growth in information services.
RELX operates in sectors benefiting from secular trends in data analytics, scientific information, and legal tech, positioning it well for future growth.
RELX exhibits robust profitability, strong cash flow generation, and a healthy balance sheet. Its valuation metrics are reasonable given its consistent performance and growth.
The stock shows a mixed technical picture. While it has shown positive short-term performance (5D, 1M, 6M, YTD, 1Y), many short-term indicators suggest a neutral to slightly bearish stance, potentially indicating a period of consolidation or minor pullback before further upward movement.
| Factor | Score |
|---|---|
| Information-Based Analytics | 85 |
| Scientific, Technical & Medical Information | 80 |
| Legal Information and Analytics | 75 |
| Exhibitions (Events) | 60 |
| Digital Transformation | 80 |
| Factor | Score |
|---|---|
| Valuation | 65 |
| Profitability | 88 |
| Growth | 75 |
| Balance Sheet Health | 70 |
| Cash Flow | 90 |
| Dividends | 70 |
| Factor | Score |
|---|---|
| Trend Analysis | 70 |
| Momentum | 65 |
| Short-Term Momentum | 70 |
| Support and Resistance | 75 |
| Trading Volume | 70 |
Consistent Revenue Growth and Strong Net Income
Revenue grew from $7.24B in 2021 to $9.43B in 2024, and Net Income has been consistently strong, reaching $1.93B in 2024 with a healthy net margin of 20.5%.
Reasonable P/E Ratio relative to historical performance
The trailing P/E ratio of 38.64 is higher than the 2021 P/E of 37.8, but the growth in earnings has been substantial, suggesting the current P/E may be justified by earnings momentum.
High P/E Ratio
The current P/E ratio of 38.64 is relatively high, particularly compared to the EPS of $1.39. This suggests that the stock might be overvalued if future earnings growth does not meet market expectations.
Slowing Revenue Growth
While revenue has grown, the net margin has fluctuated, and the P/S ratio has been around 7.7 to 11.5 in recent years, indicating that revenue growth might be slowing or facing pricing pressures.
May 2025
9
Ex-Dividend Date
June 2025
25
Next Dividend Date
July 2025
24
Next Earnings Date
H: $
A: $
L: $
RELX PLC, together with its subsidiaries, provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk. The Scientific, Technical & Medical segment provides scientific and medical information and data sets that help researchers and healthcare professionals to advance science and health outcomes. The Legal segment provides legal, regulatory, and business information and analytics that help customers in decision-making, as well as increases the productivity. The Exhibitions segment is involved in the business that combines face-to-face with data and digital tools to help customers learn about markets, source products, and transactions. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. RELX PLC was incorporated in 1903 and is headquartered in London, the United Kingdom.
56.45 USD
The 39 analysts offering 1 year price forecasts for RELX have a max estimate of 60.90 and a min estimate of 52.00.